Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply chain

Six in ten UK hospital pharmacists encounter medicines shortages daily, finds survey

A survey including responses from nearly 300 UK hospital pharmacists shows the growing prevalence of medicines shortages on a daily basis.

Hospital pharmacy waiting area

Source: Imagedoc / Alamy Stock Photo

The European Association of Hospital Pharmacists’ survey of hospital pharmacists shows an increase in the prevalence of medicines shortages

Six in ten hospital pharmacists in the UK have reported experiencing medicines shortages every day, according to a new survey carried out by the European Association of Hospital Pharmacists (EAHP).

The survey, the results of which were published in a report on 7 November 2018, asked a total of 1,666 hospital pharmacists in 38 countries about their experiences with medicines shortages.

It found that 36% of hospital pharmacists experience shortages on a daily basis across the EU.

However, the survey revealed the shortages are experienced at nearly twice that rate in the UK, with 60% of hospital pharmacists reporting daily medicines shortages.

Participants included 291 pharmacists working in UK hospitals, just under 30% of whom said they experience medicines shortages on a weekly basis — nearly 10% less than those working in the EU (39%).

The EAHP, which represents more than 22,000 hospital pharmacists in 35 European countries, said in its report that the issues with medicines shortages “have become more problematic” since its last survey in 2014, with 92% of respondents in 2018 reporting that the shortages are a problem compared with 86% in 2014.

The survey report said that the three drugs most commonly in short supply were antimicrobial agents, preventive medicines (such as vaccines) and oncology medicines.

It added that over half of respondents “have seen patient care delayed as a consequence of medication shortages” and said the pharmacists had reported 12 deaths “as a result of medication shortages”.

In May 2018 the European Industrial Pharmacists Group warned that medicines shortages in the EU could get worse following the launch of the Falsified Medicines Directive and Brexit, early in 2019.

When questioned about proposed policy solutions, nearly eight in ten of surveyed the pharmacists called for “greater legal clarity on the responsibility of manufacturers to report upcoming supply chain issues at an early stage”.

In a statement issued alongside the survey, the EAHP called on “national governments and the European Commission to improve the communication on medicines shortages”, adding that the survey revealed some cases of pharmacists” not being aware of supply issues until a delivery did not show up”.

Petr Horák, president of the EAHP, said the results of the survey “underline again that medicines shortages are a pan-European problem that cannot be solved through national measures alone.

“Consequently, the European Commission should gather information on the factors causing medicines shortages and start to provide solutions that will help to solve preventable shortages,” he added.

Jackie Eastwood, associate director of medicines optimisation and pharmacy procurement at NHS London Procurement Partnership, said: “We are not aware of any good evidence that the number of shortages the UK experiences is higher than in the rest of EU.”

However, she added: “We are definitely, however, experiencing a growing number of shortages of essential medicines in primary and acute care. A great deal of effort at all levels is being directed at trying to pre-empt them and managing and mitigating them when they do occur.

“Maintaining strong working relationships and timely effective communication between all stakeholders is a key part of this effort.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205713

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £133.00Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £252.00Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Hospital pharmacy waiting area

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.